Find generic entry opportunities
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Manage your formulary budget
Drug patents …
… from Kazakhstan to Kalamazoo
Proactively manage your pharmacy inventory
Anticipate generic drug launch
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Physiological Effect||Microtubule Inhibition |
|Active Rx/OTC/Discontinued:||RX||Dosage:||FOR SUSPENSION;IV (INFUSION)||Strength||100MG/VIAL|
|Approval Date:||Jan 7, 2005||TE:||RLD:||Yes|
|Regulatory Exclusivity Expiration:||Oct 11, 2015|
|Regulatory Exclusivity Use:||FIRST-LINE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER, IN COMBINATION WITH CARBOPLATIN, IN PATIENTS WHO ARE NOT CANDIDATES FOR CURATIVE SURGERY OR RADIATION THERAPY|
|Regulatory Exclusivity Expiration:||Sep 6, 2016|
|Regulatory Exclusivity Use:||FIRST-LINE TREATMENT OF PATIENTS WITH METASTATIC ADENOCARACINOMA OF THE PANCREAS, IN COMBINATION WITH GEMCITABINE|
|Regulatory Exclusivity Expiration:||Sep 6, 2020|
|Regulatory Exclusivity Use:||ORPHAN DRUG EXCLUSIVITY|
These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Patent No.||Patent Expiration|
|FOR SUSPENSION;IV (INFUSION)||021660-001||Jan 7, 2005||5,439,686||► subscribe|
|FOR SUSPENSION;IV (INFUSION)||021660-001||Jan 7, 2005||6,753,006||► subscribe|
|FOR SUSPENSION;IV (INFUSION)||021660-001||Jan 7, 2005||6,537,579||► subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.